一种新型原代地鼠肾细胞(PHKC)精制狂犬病疫苗的实验室质量评估  

Evaluation of a new inactivated primary hamster kidney cell(PHKC)purified rabies vaccine for human by laboratory tests

作　　者：于洪涛[1] 胡晓明[1] 荣爱红[1] 李淑兰[1] 刘殿峰[1] 郭海英[1] 刘建华[1] 杨宇飞[1] 刘增顺[2] 郑海发[2] 曲小素[2] 刘景华[2] 吴小红[2] 张永喜 朴文杰 潘燕凯 

机构地区：[1]长春生物制品研究所,北京130062 [2]中国药品生物制品检定所,北京100050 [3]黑龙江省8511农场,密山158307

出　　处：《微生物学免疫学进展》2000年第4期8-11,共4页Progress In Microbiology and Immunology

摘　　要：本文通过对一种新型疫苗 PHKC精制狂犬病疫苗的全面实验室检定并与法国Vero细胞狂犬病疫苗比较 ,认为该疫苗安全性良好 ,纯度较高 。A newly purified rabies vaccine from PHKC has been used in human.This vaccine was first tested for purity,safety and protective capacity in a series of laboratory tests. Compared with Vero cell rabies vaccine(France)of similar immune efficacy.The results indicated that the new vaccine was excellently safety, and its protective activity in conformation with the France rabies vaccine.

关 键 词：PHKC 狂犬病疫苗 纯度 副反应 免疫 质量控制 

分 类 号：R392－33[医药卫生—免疫学] R512.990.1[医药卫生—基础医学]